UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

Date of Report (date of earliest event reported): ~~March~~October 510, 2013 (~~February~~October 197, 2013)

American Oriental Bioengineering, Inc.

(Exact name of registrant as specified in charter)

Nevada

(State or other jurisdiction of incorporation)

001-32569		84-0605867
(Commission File Number)		(IRS Employer Identification No.)

1 Liangshuihe First Ave, Beijing E-Town Economic and Technology Development ~~Zone~~ Area, E-Town,

1Beijing, ~~First~~100176, ~~Liangshuihe~~People’s ~~Street~~Republic of China

E-town, Beijing 100176

People’s Republic of China

(Address of principal executive offices and zip code)

~~011-~~ 86-~~451~~10-~~8666~~5982-~~6601~~2039

(Registrant'’s telephone number including ~~area~~ area code)

(Registrant'’s former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

£ [_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

£ [_] Soliciting material pursuant to to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

£ [_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

£ [_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 25.0403. ~~Triggering~~Amendments ~~Events~~to ~~That~~Articles ~~Accelerate~~of orIncorporation ~~Increase a Direct Financial Obligation~~ or anBylaws; ~~Obligation~~Change ~~under~~in anFiscal ~~Off-Balance Sheet Arrangement~~Year.

On ~~February~~October 197, 2013, American Oriental Bioengineering, Inc. (the “Company”), ~~received~~filed aan ~~notice~~Amendment to the Certificate of ~~acceleration~~Designation ~~under~~of the ~~terms~~Preferred Stock of the Company’s ~~5.00%~~with ~~Convertible~~the ~~Senior~~Secretary ~~Notes due~~of ~~2015~~State ~~(the~~of ~~“Notes”)~~Nevada. ~~issued~~Paragraph ~~pursuant~~5 toof anthe ~~Indenture,~~Certificate ~~dated as~~ of ~~July 15~~Designation, ~~2008,~~which ~~between~~governs the ~~Company and Wells Fargo~~voting ~~Bank,~~power ~~National~~with ~~Association,~~respect asto ~~Indenture Trustee (~~the ~~“Indenture”).~~Company’s ~~The~~Preferred ~~notice~~Stock, was ~~sent~~amended byto ~~certain~~include ~~holders~~a ofprovision ~~the Notes~~ that ~~together~~allows ~~hold~~the ~~more~~1,000,000 issued ~~than~~and ~~25%~~outstanding shares of ~~the~~Preferred ~~aggregate~~Stock ~~principal~~to ~~amount~~have ofan ~~the~~aggregate ~~Notes.~~voting ~~The~~power ~~notice~~of ~~states~~25% ~~that~~of the ~~default~~shares ~~is the result~~ of the Company’s ~~failure~~common tostock ~~(A)~~with ~~pay~~respect to ~~the~~any ~~holders~~matters ~~under~~upon ~~the~~which ~~terms~~only a vote of the ~~Indenture~~holders ~~accrued~~of ~~interest~~the ~~due~~Company’s ~~and payable on each~~Common ofstock ~~July~~is ~~16,~~required. ~~2012~~This ~~and~~right ~~January~~is ~~15,2013,~~in ~~which~~addition ~~failure~~ to ~~pay~~the ~~continued~~aggregate ~~for~~voting apower ~~period~~ of ~~thirty~~25% ~~(30)~~of ~~days~~the ~~after~~combined ~~July~~voting ~~16,~~power ~~2012~~of ~~and~~the ~~January~~entire ~~15,~~Company’s ~~2013,~~shares ~~respectively,~~of ~~and~~Common ~~(B)~~Stock ~~provide,~~and ~~pursuant~~Preferred toStock ~~the~~with ~~terms~~respect ofto ~~the~~any ~~Indenture,~~matters aupon ~~notice~~which of the ~~termination~~Common ofStock ~~trading~~ and ~~delisting~~ ofPreferred ~~the~~Stock ~~Company’s~~may ~~common~~vote, which ~~stock~~is byalready ~~the~~provided ~~New~~for ~~York~~in ~~Stock~~Paragraph ~~Exchange.~~5 As of ~~March 4, 2013,~~ the ~~aggregate~~Certificate ~~principal amount~~ of ~~the Notes, and unpaid, but accrued interest was $50,161,000~~Designation.

~~The~~A ~~notice~~copy of ~~acceleration resulted in~~ the ~~principal~~Amendment ~~amount~~to ofCertificate ~~the~~of ~~Senior~~Designation ~~Convertible~~After ~~Notes~~Issuance ~~plus~~of ~~accrued~~Class ~~and~~or ~~all~~Series ~~unpaid~~is ~~interest~~attached ~~and~~to ~~accrued~~this ~~and~~Current ~~unpaid~~Report ~~Additional Interest (as defined in the Indenture)~~ on ~~the~~Form ~~Notes~~8-K ~~through~~as ~~February~~Exhibit ~~19, 2013, to become immediately due and payable~~3.1.

~~SIGNATURES~~Item 9.01 Financial Statements and Exhibits.

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~ (d) Exhibits

	AMERICAN ORIENTAL BIOENGINEERING, INC.
Exhibit No.	Description
	By: /s/ Tony Liu
3.1	Amendment to Certificate of Designation After Issuance of Class or Series §78.1955
	Name: Tony Liu
	Title: Chairman and Chief Executive Officer
Dated: March 5, 2013

3SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AMERICAN ORIENTAL BIOENGINEERING, INC.

	By:	/s/ Tony Liu
	Name:	Tony Liu
	Title:	Chairman and Chief Executive Officer

Dated: October 10, 2013

Exhibit Index

Exhibit No.	Description
3.1	Amendment to Certificate of Designation After Issuance of Class or Series §78.1955

Filing Compare · AMERICAN ORIENTAL BIOENGINEERING INC